BioSpace News Archive

TC Biopharm (Holdings) PLC today announced that several key executives will speak at The 3rd Gamma Delta T Therapies Summit, which will take place on July 26-28, 2022 in Boston, MA.

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that data from the company’s Phase 1 study of zanidatamab zovodotin (ZW49), an investigational novel bispecific HER2 targeted antibody-drug conjugate, were accepted for an oral presentation at the European Society for Medical Oncology Congress 2022 in Paris.

Tikcro Technologies Ltd. (in liquidation) (OTC: TIKRF) today announced that the liquidation trustee has substantially completed the process of winding down the affairs of the Company.

Altamira Therapeutics (“Altamira” or the “Company”) (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced the initiation of a development program based on its proprietary OligoPhore TM delivery platform and siRNA targeting NF-κB, for a novel generation of rheumatoid arthritis (RA) therapeutics.

SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022.

Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, has named Mike Waters as chief operating officer.

AcuFocus, Inc., a privately held ophthalmic medical device company, today announced U.S. Food and Drug Administration (FDA) approval for its breakthrough IC-8® Apthera™ intraocular lens (IOL) for the treatment of cataracts.

Codex Beauty Labs, Silicon Valley’s plant-based biotech skincare company launched its third collection called Shaant, that addresses oily and acne-prone skin by helping to reduce sebum production, exfoliate, encourage skin turnover and soothe irritation.

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Monday, August 15, 2022, at 4:30 p.m. Eastern Time to review 2022 second quarter results.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global scleroderma diagnostics and therapeutics market in recent times.